P
10.17
-1.08 (-9.60%)
| Penutupan Terdahulu | 11.25 |
| Buka | 11.20 |
| Jumlah Dagangan | 1,557,933 |
| Purata Dagangan (3B) | 1,517,685 |
| Modal Pasaran | 903,140,288 |
| Harga / Jualan (P/S) | 11.41 |
| Harga / Buku (P/B) | 4.84 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -98.10% |
| Margin Operasi (TTM) | -85.88% |
| EPS Cair (TTM) | -1.29 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.81% |
| Nisbah Semasa (MRQ) | 6.91 |
| Aliran Tunai Operasi (OCF TTM) | -42.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -23.09 M |
| Pulangan Atas Aset (ROA TTM) | -17.90% |
| Pulangan Atas Ekuiti (ROE TTM) | -51.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Menaik |
| Diagnostics & Research (Global) | Menaik | Menaik | |
| Stok | Personalis, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.5
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 31.49% |
| % Dimiliki oleh Institusi | 46.11% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 13.00 (Guggenheim, 27.83%) | Beli |
| 13.00 (HC Wainwright & Co., 27.83%) | Beli | |
| Median | 12.50 (22.91%) | |
| Rendah | 11.00 (Morgan Stanley, 8.16%) | Pegang |
| Purata | 12.25 (20.45%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 9.25 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Guggenheim | 26 Jan 2026 | 13.00 (27.83%) | Beli | 10.36 |
| 11 Nov 2025 | 12.00 (17.99%) | Beli | 8.44 | |
| BTIG | 09 Jan 2026 | 12.00 (17.99%) | Beli | 8.10 |
| 11 Nov 2025 | 12.00 (17.99%) | Beli | 8.44 | |
| Morgan Stanley | 02 Dec 2025 | 11.00 (8.16%) | Pegang | 10.10 |
| 11 Nov 2025 | 9.00 (-11.50%) | Pegang | 8.44 | |
| HC Wainwright & Co. | 11 Nov 2025 | 13.00 (27.83%) | Beli | 8.44 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |